Berenguer J, Carrasco D. Double-blind trial of silymarin vs. placebo in the treatment of chronic hepatitis.
Munch Med Wochenschr. 1977;119:240 - 260.
Buzzelli G, Moscarella S, Giusti A, et al. A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB 1016) in chronic active hepatitis.
Int J Clin Pharmacol Ther Toxicol. 1993;31:456 - 460.
Lirussi F, Okolicsanyi L. Cytoprotection in the nineties: Experience with ursodeoxycholic acid and silymarin in chronic liver disease.
Acta Physiol Hung. 1992;80:363 - 367.
Magliulo E, Gagliardi B, Fiori GP. Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres [translated from German].
Med Klin. 1978;73:1060 - 1065.
Bode JC, Schmidt U, Durr HK. Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial [translated from German].
Med Klin. 1977;72:513 - 518.
Magliulo E, Gagliardi B, Fiori GP. Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres [translated from German].
Med Klin. 1978;73:1060 - 1065.
Schulz V, Hansel R, Tyler VE.
Rational Phytotherapy: A Physicians' Guide to Herbal Medicin
e. 3rd ed. Berlin, Germany: Springer-Verlag; 1998:216.
Hikino H, Kiso Y. Natural products for liver disease.
Econ Med Plant Res. 1988;2:39 - 72.
Muzes G, Deak G, Lang I, et al. Effects of silymarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease [in Hungarian].
Orv Hetil. 1990;131:863 - 866.
Lorenz D, Lucker PW, Mennicke WH, et al. Pharmacokinetic studies with silymarin in human serum and bile.
Methods Find Exp Clin Pharmacol. 1984;6:655 - 661.
Dehmlow C, Erhard J, de Groot H. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin.
Hepatology. 1996;23:749 - 754.
Comoglio A, Tomasi A, Malandrino S, et al. Scavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicals.
Biochem Pharmacol. 1995;50:1313 - 1316.
Arase Y, Ikeda K, Murashima N, et al. The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
Cancer. 1997;79:1494 - 1500.
Liu JP, McIntosh H, Lin H. Chinese medicinal herbs for chronic hepatitis B (Cochrane Review).
Cochrane Database Syst Rev.
2001;(1):1-27, +7 tables.
Civeira MP, Castilla A, Morte S, et al. A pilot study of thymus extract in chronic non-A, non-B hepatitis.
Aliment Pharmacol Ther. 1989;3:395 - 401.
Bortolotti F, Cadrobbi P, Crivellaro C, et al. Effect of an orally administered thymic derivative, thymomodulin, in chronic type B hepatitis in children.
Curr Ther Res.
1988;43:67 - 72.
Galli M, Crocchiolo P, Negri C, et al. Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results.
Drugs Exp Clin Res.1985;11:665 - 669.
Raymond RS, Fallon MB, Abrams GA. Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.
1998;129:797 - 800.
Berk L, de Man RA, Schalm SW, et al. Beneficial effects of Phyllanthus amarus for chronic hepatitis B.
J Hepatol. 1991;12:405 - 406.
Calixto JB, Santos AR, Cechinel Filho V, et al. A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential.
Med Res Rev. 1998;18:225 - 258.
Leelarasamee A, Trakulsomboon S, Maunwongyathi P, et al. Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers.
Lancet. 1990;335:1600 - 1601.
Thyagarajan SP, Jayaram S, Valliammai T, et al. Phyllanthus amarus and hepatitis B.
Lancet. 1990;336:949 - 950.
Thamlikitkul V, Wasuwat S, Kanchanapee P. Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers.
J Med Assoc Thai. 1991;74:381 - 385.
Doshi JC, Vaidya AB, Antarkar DS, et al. A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen.
Indian J Gastroenterol. 1994;13:7 - 8.
Milne A, Hopkirk N, Lucas CR, et al. Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus.
Med J. 1994;107:243.
Narendranathan M, Remla A, Mini PC, et al. A trial of Phyllanthus amarus in acute viral hepatitis.
Trop Gastroenterol. 1999;20:164 - 166.
Wang M, Cheng H, Li Y, et al. Herbs of the genus phyllanthus in the treatment of chronic hepatitis B: observation with three preparations from different geographic sites.
J Lab Clin Med. 1995;126:350 - 352.
Thyagarajan SP, Subramanian S, Thirunalasundar T, et al. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus.
Lancet. 1988;2:764 - 766.
Japanese Health Ministry Confirms Effectiveness of Tsumura's Top-selling Kampo Herbal Prescription. Kampo Today [serial online]. 1995;1. Available at: <
http://www.tsumura.co.jp/english/kthp/1-2-01.htm. Accessed November 4, 2002.
Hirayama C, Okumura M, Tanikawa K, et al. A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis. .
Gastroenterol Jpn
1989;24:715 - 719.
McCulloch M, Broffman M, Gao J, et al. Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials.
Am J Public Health.
2002;92:1619 - 1628.
Liu JP, McIntosh H, Lin H. Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection.
Cochrane Database Syst Rev.
2001;CD002231.
Liu JP, Manheimer E, Tsutani K, et al. Medicinal herbs for hepatitis C virus infection.
Cochrane Database Syst Rev.
2001;CD003183.
Liu JP, McIntosh H, Lin H. Chinese medicinal herbs for chronic hepatitis B.
Cochrane Database Syst Rev.
2001;CD001940.
Verucchi G, Calza L, Attard L, et al. Acute hepatitis induced by traditional Chinese herbs used in the treatment of psoriasis.
J Gastroenterol Hepatol.
2002;17:1342 - 1345.
Das DG. A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis.
Indian J Gastroenterol.
1993;12:126 - 128.
Saxena S, Garg AK, Jain A. Liv.52 in Infective Hepatitis. A study of Liv.52 therapy in infective hepatitis in children.
Current Medical Practice.
1980;5:194.
Sama SK, Krishnamurthy L, Ramachandran K, et al. Efficacy of Liv.52 in acute viral hepatitis. A double-blind study.
Indian J Med Res.
1976;5:738.
Mendal JN, Roy BK. Studies with Liv.52 in the treatment of infective hepatitis, chronic Active hepatitis and cirrhosis of the liver.
Probe.
1983;22:217.
Vaidya AB, Antarkar DS, Doshi JC, et al. Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent - experimental & clinical studies.
J Postgrad Med.
1996;42:105 - 108.
Frezza M, Surrenti C, Manzillo G, et al. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study.
Gastroenterology
1990;99:211 - 215.
Niederau C, Strohmeyer G, Heintges T, et al. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Hepatogastroenterology.
1998;45:797 - 804.
Guan R, Ho KY, Kang JY, et al. The effect of polyunsaturated phosphatidyl choline in the treatment of acute viral hepatitis.
Aliment Pharmacol Ther.
1995;9:699 - 703.
European Scientific Cooperative on Phytotherapy. Valerianae radix. Exeter, UK: ESCOP; 1996 - 1997:2. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 4.
Chan TY, Tang CH, Critchley JA. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian).
Postgrad Med J.
1995;71:227 - 228.
Chan TY. An assessment of the delayed effects associated with valerian overdose [letter]. Int
J Clin Pharmacol Ther.
1998;36:569.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.